What does digoxin do
Pro Research Analysisby 
Searched over 200M research papers
Understanding the Multifaceted Role of Digoxin
Digoxin in Heart Failure and Arrhythmia Treatment
Digoxin is a cardiac glycoside primarily used to treat heart failure and various types of arrhythmias, including atrial fibrillation and flutter 259. It works by increasing the force of myocardial contractions and modulating neurohormonal activity, which helps improve cardiac output and reduce symptoms of heart failure without significantly affecting heart rate or blood pressure 610. Despite its long history of use, digoxin's role in contemporary heart failure management remains somewhat controversial due to its narrow therapeutic window and potential for toxicity 25.
Digoxin's Anticancer Potential
Recent studies have explored digoxin's potential as an anticancer agent. In non-small cell lung cancer (NSCLC), digoxin has been shown to reduce cell viability, increase DNA damage, and inhibit DNA repair mechanisms, thereby enhancing the efficacy of other anticancer drugs like adriamycin while reducing their cardiotoxicity . Additionally, digoxin has demonstrated anti-proliferative effects on breast cancer cells by inducing apoptosis through the modulation of Bcl-2 and Bax protein levels 78. These findings suggest that digoxin could be repurposed as an adjunct therapy in cancer treatment.
Anti-Inflammatory and Immunomodulatory Effects
Digoxin also exhibits significant anti-inflammatory properties. In a study on collagen-induced arthritis (CIA) in mice, digoxin was found to suppress the incidence and severity of arthritis by reducing the expression of pro-inflammatory cytokines and inhibiting Th17 cell differentiation . This suggests that digoxin could be beneficial in treating autoimmune diseases by modulating immune responses and reducing inflammation.
Mechanisms of Action in Cancer Therapy
The anticancer effects of digoxin are partly attributed to its ability to inhibit hypoxia-inducible factor 1-alpha (HIF-1α), a key regulator of cellular response to hypoxia. In NSCLC cells, digoxin downregulated the expression of HIF-1α and its downstream targets, VEGF and NDRG1, thereby inhibiting tumor growth under hypoxic conditions . This mechanism highlights digoxin's potential to interfere with tumor adaptation to low oxygen environments, a common feature in solid tumors.
Drug Interactions and Safety Concerns
While digoxin is effective in treating heart conditions and shows promise in cancer therapy, its use is complicated by significant drug interactions and a narrow therapeutic index. Traditional Chinese Medicine (TCM) formulations, for instance, can alter digoxin's pharmacokinetics by affecting gastrointestinal motility, gastric pH, and P-glycoprotein levels, leading to potential adverse reactions . Therefore, careful monitoring and dose adjustments are essential when digoxin is used in combination with other medications.
Conclusion
Digoxin remains a valuable drug in the treatment of heart failure and arrhythmias, with emerging roles in cancer therapy and autoimmune disease management. However, its narrow therapeutic window and potential for drug interactions necessitate careful clinical management to maximize its benefits while minimizing risks. Further research is needed to fully understand and harness digoxin's multifaceted therapeutic potential.
Sources and full results
Most relevant research papers on this topic